OAOlusegun Adebayo Adeoluwa

Olusegun Adebayo Adeoluwa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Olusegun Adebayo Adeoluwa has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Quercetin Exerts Anticonvulsant Effect through Mitigation of Neuroinflammatory Response in Pentylenetetrazole-induced Seizure in Mice

    by Adewale Ganiyu Bakre, O.A. Adeoluwa, G.O. Adeoluwa, F.R. Adeniyi, J.O. Oni, E.T. Akinluyi, S.O. Olojede

    Epilepsy is a chronic disease of the brain characterized by seizures. The currently available anticonvulsants only treat symptoms with serious adverse drug reactions. Therefore, there is need for new therapeutic intervention that will prevent epileptogenesis with greater therapeutic success. Quercetin (QT) is a flavonoid with known neuroprotective and anti-inflammatory properties. The study aimed to investigate its effects against pentylenetetrazole (PTZ)-induced seizures. Animals were divided into four groups (n = 10). Group 1(control) only received vehicle (10 mL/kg), group 2 received vehicle, groups 3 and 4 received QT 12.5 mg/kg and 25 mg/kg respectively. Sixty minutes after treatments, animals in groups 2 to 4 were injected with sub-convulsive dose of pentylenetetrazole (35 mg/kg, i.p.) on every alternate day (48±2h) for 21 days. The mice were observed for 30 minutes after each PTZ injection for seizure activity. Brain samples were collected for biochemical assays. Administration of PTZ caused significant increase in the intensity of seizures, neuronal degeneration and level of proinflammatory cytokines in animals compared to control. These behavioural alterations were attenuated significantly by QT (12.5 and 25 mg/kg). The PTZ-induced increase in IL-12, TNF-α and IFN-ɣ were significantly reduced by pre-treatment with the QT (12.5 and 25 mg/kg, p.o). Quercetin also reduced neuronal loss compared to control. Quercetin attenuates seizures in kindled mice and reduces neuroinflammation and neurodegeneration. This neuroprotective effect may be attributed to its ability to inhibit inflammatory mediators in the brain


  • Open Access

    QUERCETIN MITIGATES SCOPOLAMINE -INDUCED MEMORY DYSFUNCTION: IMPACT ON OXIDATIVE STRESS AND CHOLINERGIC MECHANISMS

    by Juliet Olayinka, Anthony Eduviere, Olusegun Adeoluwa, Elizabeth Akinluyi, Abiola Obisesan, Oluwole Akawa, Adeshina Adebanjo

  • The monoaminergic pathways are involved in the antidepressant-like effect of quercetin

    by Olusegun Adebayo Adeoluwa, Anthony Taghogho Eduviere, Gladys Onyinye Adeoluwa, Lily Oghenevovwero Otomewo, Funmilayo Racheal Adeniyi

    Quercetin, a plant-derived flavonoid, is an antioxidant and has demonstrated antidepressant and anti-inflammatory activities in several animal models. However, there is scanty information on the underlying mechanisms of its antidepressant property. This present study aimed at assessing the involvement of monoaminergic systems in the antidepressant-like activity of quercetin in experimental animals. Mice received varying doses of quercetin (25, 50 &100 mg/kg daily) and were then subjected to open field test (OPF), despair tests, the reserpine test, and the yohimbine lethality test (YLT). In addition, monoaminergic involvement was investigated by combining quercetin (100 mg/kg) with dopaminergic antagonists (haloperidol and sulpiride), adrenergic blockers (prazosin, propranolol and yohimbine), and serotonergic blockers/inhibitors (metergoline). The results showed that quercetin produced significant anti-immobility effects in the forced swim test (FST) and tail suspension test (TST), suggesting antidepressant activity. In addition, the potentiation of yohimbine lethality by quercetin further indicates its antidepressant-like property. This antidepressant action demonstrated was, however, blocked when quercetin was co-administered with dopaminergic, adrenergic and serotonergic antagonists, suggesting involvement of the monoaminergic system in the antidepressant action of quercetin. Nevertheless, quercetin did not significantly alter the locomotor activity of mice, which implies lack of stimulant effect. Taken together, these outcomes suggest that monoaminergic systems are likely involved in the anti-depressant effect of quercetin in mice.


  • Open Access

    Evaluation of Antidepressant-Like Activity of Solvent Partitioned Fractions of Olax subscorpioidea Oliv. (Olacaceae) Leaf Extract in Rodents

    by Olusegun A. Adeoluwa, Isaiah O. Agboola, Elizabeth T. Akinluyi, Gladys O. Adeoluwa, Adegbuyi O. Aderibigbe

    Olax subscorpioidea is a medicinal plant with a long history in traditional medicine for the treatment of mental illness in Nigeria. The current study investigated antidepressant-like activity of solvent partitioned fractions. The crude extract was partitioned in increasing order of polarity to yield ethyl-acetate fraction (EAF), butanol fraction (BF) and aqueous fraction (AF). They were evaluated for antidepressant activity at doses of 5-20 mg/kg in mice using the forced swim test, tail suspension and reserpine tests. The BF, the most active was adsorbed on silica gel and subjected to vacuum liquid chromatography to yields several fractions which were subsequently pooled into five sub-fractions, F1-F5 and screened for antidepressant action. F1 being the most active one was subjected to column chromatography with n-hexane, dichloromethane and ethylacetate. The yields of twenty-six fractions were pooled into four fractions f1-f4 and were screened with the FST and TST only. The EAF, BF, F1, f1, f2, f3 and f4 fractions significantly (P<0.05) reduced immobility in the FST and TST without locomotor effect. The BF and F1 significantly (P<0.05) reversed reserpine-induced hypothermia. From the data obtained, it was observed that among all the fractions, BF, F1, f1, f2, f3 and f4 possess prominent antidepressant-like and antiimmobility effects in both FST and TST. This activity increases as the extract and fractions were further separated. This shows that the plant may have important phytochemicals with great potential for the development of a new antidepressant, thus justifying the traditional use of the plant in mental illness.


  • Quercetin abrogates lipopolysaccharide-induced depressive-like symptoms by inhibiting neuroinflammation via microglial NLRP3/NFκB/iNOS signaling pathway

    by Olusegun Adebayo Adeoluwa, Juliet Nneda Olayinka, Gladys Onyinye Adeoluwa, Elizabeth Toyin Akinluyi, Funmilayo Racheal Adeniyi, Adedamola Fafure, Kate Nebo, Edem Ekpenyong Edem, Anthony Taghogho Eduviere, Badamasi Abubakar


  • Open Access

    N-butanol fraction of Olax subscorpioidea Oliv. (Olacaceae) attenuates lipopolysaccharide-induced depressive-like symptoms in mice.

    by Olusegun Adebayo Adeoluwa, Isaiah Agboola, Elizabeth Akinluyi, Anthony Eduviere, Gladys Adeoluwa, Abayomi Ajayi, Adegbuyi Aderibigbe

    Background: The leaves of Olax subscorpioidea have become a mainstay in the management of inflammatory diseases and mental illness in folkloric medicine in Nigeria. Previous studies have shown its antidepressant and anti-inflammatory properties in experimental animals. Recently its antidepressant action was linked to the involvement of monoaminergic transmission. However, with accumulating evidences suggesting link between immuno-inflammatory signaling pathways and depression, there is dearth of information about its beneficial effect on inflammation associated depression. We thus evaluated the effect of n-butanol fraction of O. subscorpioidea leaves on lipopolysaccharide (LPS)-induced depressive-like behaviours and investigated its antidepressant effect with respect to its action on inflammatory and oxidative pathways. Methods: Fifty Swiss male mice were randomly assigned into five groups (n= 10): group 1 (vehicle only), group 2 (nBFOS 5mg/kg), group 3 (nBFOS 10 mg/kg), group 4 (imipramine 10 mg/kg), group 5 (vehicle). Mice were treated with vehicle or nBFOS (5 & 10 mg/kg) or imipramine intraperitoneal for seven days. Thirty minutes after treatment on day seven, animals were injected with LPS (0.83 mg/kg, i.p.) except group 1 (vehicle only). Twenty-four hours following LPS injection, animals were assessed for depressive symptoms using sucrose preference test and immobility using tail suspension test (TST). Brain levels of pro-inflammatory mediators interleukin-1β (IL-1β) and tumor necrosis factor (TNF), oxidative stress biomarkers (malondialdehyde and reduced glutathione) and plasma level of corticosterone were measured by Enzyme Linked immunosorbent assay. Results: LPS significantly (p < 0.05) increased immobility of mice in TST and decreased sucrose preference which is indicative of depressive-like behaviours. The depressive behaviours were significantly (p < 0.05) attenuated by nBFOS and imipramine compared to control. Furthermore, LPS-induced increase in malondialdehyde, corticosterone, TNF, IL-1β, and decrease in reduced glutathione, in the brain were significantly reversed by treatment with nBFOS and imipramine. Conclusion: The findings suggest that attenuation of LPS-induced depressive-like behaviours by the fraction of O. subscorpioidea leaves may be related to suppression of oxidative stress and inhibitory effect on inflammatory mediators in the central nervous system.

  • Open Access

    Ameliorating Effect of Morin Hydrate on Chronic Restraint Stress-induced Biochemical Disruption, Neuronal, and Behavioral Dysfunctions in BALB/c Mice

    by Elizabeth Akinluyi, Adegbuyi Aderibigbe, Olusegun Adeoluwa, Adaeze Adebesin, Gladys Adeoluwa

    Introduction: Morin hydrate (MH) is a bioflavonoid component of many fruits and vegetables. Our previous research demonstrated that MH provides neuroprotection in mouse models of acute restraint stress and sleep deprivation by attenuating hippocampal neuronal damage and enhancing memory. Based on these findings, our study investigated the role of MH in chronic stress-induced neuronal and biochemical perturbations in BALB/c mice. Methods: Male BALB/c mice were divided into 6 groups (n=6). Groups 1 and 2 received vehicle (10 mL/kg normal saline), groups 3-5 received MH (5, 10, 20 mg/kg IP), while group 6 received ginseng (25 mg/kg) daily and 30 minutes afterward were restrained in a plastic cylindrical restrainer for 14 days. Results: Immobility time in the forced swim test increased in the MH-treated group, indicating an antidepressant-like effect. Also, a reduction in frequency and duration of open arms exploration was observed in the elevated plus-maze (EPM) test in stressed mice, and administration of MH (5, 10, 20 mg/kg, IP) reversed these effects. An increase in blood levels of glucose, triglycerides, total cholesterol, and brain malondialdehyde and nitrite levels was observed in the stressed groups, which was reversed by MH. Furthermore, MH reversed the stress-induced reduction in HDL cholesterol and glutathione (GSH) levels and attenuated stress-induced alterations in the prefrontal cortex and hippocampus. Conclusion: Our findings suggest that MH attenuated chronic restraint stress-behavioral and biochemical perturbations, probably due to its capability to decrease oxidative stress and brain neuronal damage


  • Open Access

    Correction to: Morin hydrate attenuates chronic stress-induced memory impairment and degeneration of hippocampal subfields in mice: The role of oxidative, nitrergic and neuroinflammatory pathways

    by Elizabeth Akinluyi, Adegbuyi Aderibigbe, Olusegun Adeoluwa, Benneth Ben-Azu, Anthony Eduviere, Abayomi Ajayi, Solomon Umukoro


  • Butanol Fraction of Olax Subscorpioidea Produces Antidepressant Effect: Evidence for the Involvement of Monoaminergic Neurotransmission

    by Adebayo O. Adeoluwa, Oladele A. Aderibigbe, Isaiah O. Agboola, Toyin E. Olonode, Benneth Ben-Azu

    This study sought to investigate involvement of monoaminergic mechanism in the antidepressant action of butanol fraction (BF) of Olax subscorpioidea in rodents and the bioactive principles present. Butanol fraction was evaluated for antidepressant-like effect in the tail suspension, forced swimming and open field tests. All animals were treated with BF (5, 10 & 20 mg/kg) thirty minutes prior to the tests. On the other hand, monoaminergic neurotransmission involvement was probed by pre-treating animals with yohimbine hydrochloride (1 mg/kg, α2 antagonist), prazosin (62.5 µg/kg, α1 antagonist), propranolol (2 mg/kg, non-selective β antagonist), sulpiride (50 mg/kg, D2 receptor blocker), haloperidol (0.2 mg/kg, non-selective D receptor blocker), metergoline (4 mg/kg, i.p., a 5HT-receptor blocker) and PCPA (100 mg/kg, i.p., inhibitor of tryptophan hydroxylase), fifteen minute before treatment with BF (10 mg/kg). Identification of the major bioactive constituents was done by HPLC. The findings show that BF (5 & 10 mg/kg) significantly decreased immobility in despair tests of depression without effect on locomotor activity. The data also shows that anti-immobility effect of BF (10 mg/kg) in the TST was reversed by prazosin, yohimbine, haloperidol, sulpiride, metagoline and PCPA but not with propranolol. Bioactive principles present are caffeic acid, rutin, morin and quercetin. In conclusion, our findings show that BF produces antidepressant-like effect, which may be dependent on its interaction with the monoaminergic system.


  • Neurobehavioural and Analgesic Properties of Ethanol Bark Extract of Terminalia ivorensis A Chev. (Combrataceae) in Mice

    by O. A. Adeoluwa, A. O. Aderibigbe, G. O. Agu, F. A. Adewole, A. T. Eduviere

    Background: Terminalia ivorensis A. Chev (Combretaceae) is a medicinal plant used in folk medicine in the management of pain, rheumatic condition, gastroenteritis and as a tranquilizer in psychotic disorder. Objective: We evaluated neurobehavioural and analgesic properties of the ethanol bark extract of T. ivorensis (EBETI). Materials and methods: Effects of EBETI (1.25, 2.5, and 5 mg/kg) on novelty-induced behaviours were determined using open field test. Anxiolytic effect of EBETI (1.25, 2.5, and 5 mg/kg) was assessed using hole-board and elevated-plus maze paradigms. Analgesic property of EBETI (2.5, 5, and 10 mg/kg) was evaluated using acetic acid induced writhing, formalin and tail immersion tests. The extract was administered once intraperitoneally. Results: The LD50 of EBETI was 173 mg/kg. EBETI (1.25, 2.5, and 5 mg/kg) significantly reduced rearing (142.3±1.6, 83.5±1.9, 39.3±1.5) and grooming (33.8±3.4, 28.4±3.0, 18.2±1.7) as compared with controls (180.5±4.9; 52.4±5.2). Treatment with EBETI (1.25, 2.5, and 5 mg/kg) significantly reduced head-dipping on hole-board (9.4±2.3, 6.2±1.9, 5.4±2.9) as compared with control (26.8±1.9). However, there was no anxiolytic effect on EPM. EBETI (2.5, 5, and 10 mg/kg) significantly inhibited abdominal constriction in writhing assay (21.8.0±2.4, 12.2±1.6, 5.8±2.1) as compared with control (35.0±1.7). Inhibition of neurogenic and inflammatory phases of formalin test was notice. However, the extract could not alter response to thermal stimulus in tail immersion test. Discussion and conclusion: EBETI is sedative and has analgesic effect, thus supporting its folkloric use in pain management and as a tranquilizer in psychosis.